Clinical Trial Update: Efficacy and Safety of BGG492 in the Treatment of Migraine [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating efficacy and safety of BGG492 for migraine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• BGG492

Snippet

Sponsor: Novartis | Conditions: Migraine | Phase 2 | Status: COMPLETED